NEW YORK, March 14 /PRNewswire/ -- The New York Biotechnology Association (NYBA), a not-for-profit trade association dedicated to the development and growth of New York State-based biotechnology related industries, announced today that Dr. Cynthia Robbins-Roth, a highly regarded biotechnology industry insider and consultant will deliver the opening day plenary address at NYBA's Annual Meeting on April 17, 2006. Dr. Robbins-Roth's presentation is titled "Money, Products, and Politics: Industry Trends and What They Mean for New York" and will take place at the Plenary Luncheon at 12:30 pm at the Marriott Marquis Hotel in New York City.
"The breadth and depth of Cynthia's experience in biotechnology -- as a scientist, author and industry business consultant -- provides a unique perspective that will offer NYBA meeting attendees a comprehensive view of key issues that have the greatest impact for New York and beyond," said Karin Duncker, NYBA's executive director. "The New York biotech market must continue to evolve to ensure continued economic growth and scientific success. We look forward to Cynthia's insights as to how New York companies may need to create new models for moving novel scientific programs toward the marketplace and build successful businesses that can thrive in a cost-constrained environment."
Dr. Cynthia Robbins-Roth has been part of the biotechnology industry since 1981. She is a well-known speaker at industry events and a frequent contributor to industry publications, where she offers commentary on specific industry issues. Dr. Robbins-Roth started her career as a research scientist at Genentech, Inc., and then joined the business development group at California Biotechnology Inc. She has been a consultant to the Bioscience Industry since 1986, providing technology assessment, competitor analysis, strategic planning, due diligence, market analysis and fund management consultation services.
NYBA's annual two-day meeting brings together leaders in the biotechnology community to examine and discuss issues vital to the industry from a financial, public policy, research and business development perspective. More than 500 scientists, medical researchers, biotechnology business executives, investors, policy makers and journalists will convene for NYBA's 16th annual meeting.
For online program and registration information, please visit the NYBA website: http://www.nyba.org.
About NYBA
NYBA is the leading advocate for advancing the success of the biotechnology industry in New York State and is its main representative to policy makers, the media and the communities in which we work. Our mission is to support the development and growth of New York's biotechnology industry, and serve our members and the biotechnology community by providing a network for information exchange, shared services and collective action. NYBA's membership comprises over 250 bioscience companies, world-class research institutions and related professional services. Under the banner of The Cures Start Here(R), our goal is to amplify the success New York has had and continues to have in discovering major medical advances and growing a vibrant biotech industry. For more information on NYBA programs and initiatives, visit our website at http://www.nyba.org.
New York Biotechnology AssociationCONTACT: Karin Duncker, Executive Director of The New York BiotechnologyAssociation, +1-212-332-4395, kduncker@nyba.org; or Paul Kidwell of SudaCommunications, +1-617-296-3854, paulkidwell@comcast.net
Web site: http://www.nyba.org/
